UniQure Is Latest Gene Therapy Sponsor Surprised By US FDA Reversal

 
• By Bridget Silverman
  
The US FDA blocked uniQure's planned route to submission of its Huntington's disease gene therapy. (Shutterstock)

More from Cell & Gene Therapies

More from Advanced Technologies